Nasdaq: CTMX
CytomX Therapeutics insiders
The officers, directors and 10% owners of CytomX Therapeutics, Inc. who hold the most stock, valued at the live CTMX price.
$2.05
CTMX today +$170K (+9.04%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 1
- Their CTMX stock
- $120K
- Market value
- $447M
- Held by ranked insiders
- <0.1%
Insiders by value of CTMX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Amy C. Peterson | EVP, Chief Development Officer | 58,433 | $120K | <0.1% | 3706th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for CytomX Therapeutics; see each profile for the filing.